HealthQuill Zevra Therapeutics
IntraBio Inc, a biotechnology company focused on rare and neurodegenerative diseases, got the US regulator’s nod for a drug to treat a certain type of Niemann-Pick disease in adults and pediatric patients weighing about 15 kilograms.
Drugs Health Pharma

IntraBio Inc.’s drug for neurogenerative disorder gets US regulator’s nod

IntraBio Inc, a biotechnology company focused on rare and neurogenerative diseases, got the US regulator’s nod for a drug to treat a certain.

Read More
Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member nations during the two-day meeting starting in India today.
Drugs Medical Pharma

Zevra Therapeutics completes acquisition of Acer in a $91m deal

HQ Team November 21, 2023: Zevra Therapeutics, Inc. has finalized its acquisition of Acer Therapeutics Inc in a $91m deal. This strategic acquisition.

Read More